 |
|
|
| |
ADEQUATE PLASMA LEVELS OF DOLUTEGRAVIR IN COMBINATION WITH RITONAVIR-BOOSTED DARUNAVIR:
A PHARMACOKINETIC SUBGROUP-ANALYSIS OF THE DUALIS STUDY
|
| |
| |
IAC 2020 July 6-10
Reported by Jules Levin
S Weidlich1, C Boesecke2, J Schneider1, H F Klinker3, A Zink4, A Balogh5, E Wolf5, H Bidner6, and C D Spinner1* on behalf of the DUALIS study team
1 Technical University of Munich, School of Medicine, University Hospital rechtsder Isar, Department of Medicine II, Munich, Germany 2 Bonn University Hospital, Department of Medicine I, Venusberg-Campus, Bonn, Germany 3 University of WuerzburgMedical Center, Department of Medicine II, Division of Infectious Diseases, Wuerzburg, Germany 4 Technical University of Munich, School of Medicine, University Hospital rechtsder Isar, Department of Dermatology and Allergy, Munich, Germany 5 MUC Research, Clinical Research Organisation, Munich, Germany 6 Technical University of Munich, School of Medicine, University Hospital rechtsder Isar, Munich Study Center, Clinical Research Organization, Munich, Germany
|
| |
|
|
|
|
|
